APA (7th ed.) Citation

Barilli, A., Visigalli, R., Recchia Luciani, G., Crescini, E., Dall'Asta, V., & Rotoli, B. M. (2025). Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs. International Journal of Molecular Sciences, 26(17), 8672. https://doi.org/10.3390/ijms26178672

Chicago Style (17th ed.) Citation

Barilli, Amelia, Rossana Visigalli, Giulia Recchia Luciani, Eleonora Crescini, Valeria Dall'Asta, and Bianca Maria Rotoli. "Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs." International Journal of Molecular Sciences 26, no. 17 (2025): 8672. https://doi.org/10.3390/ijms26178672.

MLA (9th ed.) Citation

Barilli, Amelia, et al. "Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs." International Journal of Molecular Sciences, vol. 26, no. 17, 2025, p. 8672, https://doi.org/10.3390/ijms26178672.